What is your brain tumor story? Click here to share it. Your story matters.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
TakeAim Lymphoma – Now Enrolling ** Sponsored by Curis. This content is not an endorsement from the ABTA.** Primary CNS Lymphoma (PCNSL) Curis is a biopharmaceutical company dedicated to developing
** Sponsored by Pacific Neuroscience Institute (PNI). This content is not an endorsement from the ABTA.** By Emmaline Mauitson, MPAP, PA-C James, 75, was vacationing in Hawaii with his wife
** Sponsored by Ono Pharmaceuticals. This content is not an endorsement from the ABTA.** In her job at a healthcare insurer, Barb Brady leads a team that collaborates with primary
**Sponsored by Plus Therapeutics. This content is not an endorsement from the ABTA.** ReSPECT-GBM Patient Story | Jim, Recurrent Glioblastoma Survivor Dr. Jim Stockand, a dedicated educator with a PhD
** Sponsored by Imvax. This content is not an endorsement from the ABTA.** Imvax is a pioneering clinical biotechnology company developing personalized cancer treatments specifically designed for glioblastoma (GBM) patients.
The NIH Clinical Center is the nation’s largest hospital devoted entirely to clinical research. Clinician-investigators translate scientific observations and laboratory discoveries into new approaches to diagnosing, treating, and preventing disease.
Always free for patients & caregivers
